| UniProt ID | GBRA4_HUMAN |   | 
														
|---|---|---|
| UniProt AC | P48169 | |
| Protein Name | Gamma-aminobutyric acid receptor subunit alpha-4 | |
| Gene Name | GABRA4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 554 | |
| Subcellular Localization | 
																Cell junction, synapse, postsynaptic cell membrane Multi-pass membrane protein. Cell membrane Multi-pass membrane protein.  | 
														|
| Protein Description | GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.. | |
| Protein Sequence | MVSAKKVPAIALSAGVSFALLRFLCLAVCLNESPGQNQKEEKLCTENFTRILDSLLDGYDNRLRPGFGGPVTEVKTDIYVTSFGPVSDVEMEYTMDVFFRQTWIDKRLKYDGPIEILRLNNMMVTKVWTPDTFFRNGKKSVSHNMTAPNKLFRIMRNGTILYTMRLTISAECPMRLVDFPMDGHACPLKFGSYAYPKSEMIYTWTKGPEKSVEVPKESSSLVQYDLIGQTVSSETIKSITGEYIVMTVYFHLRRKMGYFMIQTYIPCIMTVILSQVSFWINKESVPARTVFGITTVLTMTTLSISARHSLPKVSYATAMDWFIAVCFAFVFSALIEFAAVNYFTNIQMEKAKRKTSKPPQEVPAAPVQREKHPEAPLQNTNANLNMRKRTNALVHSESDVGNRTEVGNHSSKSSTVVQESSKGTPRSYLASSPNPFSRANAAETISAARALPSASPTSIRTGYMPRKASVGSASTRHVFGSRLQRIKTTVNTIGATGKLSATPPPSAPPPSGSGTSKIDKYARILFPVTFGAFNMVYWVVYLSKDTMEKSESLM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
| 
																 | 
														||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure  | 
														ASA (%) | Reference | Orthologous Protein Cluster  | 
			    									
|---|---|---|---|---|---|
| 47 | N-linked_Glycosylation | EEKLCTENFTRILDS HHHHHHHHHHHHHHH  | 25.99 | UniProtKB CARBOHYD | |
| 76 | Phosphorylation | GPVTEVKTDIYVTSF CCCCEEEEEEEEEEE  | 32.57 | - | |
| 79 | Phosphorylation | TEVKTDIYVTSFGPV CEEEEEEEEEEECCC  | 10.65 | - | |
| 110 | Phosphorylation | WIDKRLKYDGPIEIL HHCHHCCCCCCEEEE  | 30.62 | 26074081 | |
| 125 | Phosphorylation | RLNNMMVTKVWTPDT EECCCEEEEEECCCC  | 11.28 | 26074081 | |
| 140 | Phosphorylation | FFRNGKKSVSHNMTA CCCCCCCCCCCCCCC  | 32.13 | 22115753 | |
| 142 | Phosphorylation | RNGKKSVSHNMTAPN CCCCCCCCCCCCCCC  | 19.08 | 22115753 | |
| 144 | N-linked_Glycosylation | GKKSVSHNMTAPNKL CCCCCCCCCCCCCHH  | 23.22 | UniProtKB CARBOHYD | |
| 146 | Phosphorylation | KSVSHNMTAPNKLFR CCCCCCCCCCCHHHH  | 44.26 | 22115753 | |
| 157 | N-linked_Glycosylation | KLFRIMRNGTILYTM HHHHHHCCCEEEEEE  | 34.28 | UniProtKB CARBOHYD | |
| 169 | Phosphorylation | YTMRLTISAECPMRL EEEEEEEEEECCEEE  | 16.87 | 28509920 | |
| 202 | Phosphorylation | YPKSEMIYTWTKGPE ECCHHEEEEEECCCC  | 8.56 | - | |
| 218 | Phosphorylation | SVEVPKESSSLVQYD CEECCCCCCCCEEEE  | 31.21 | 30576142 | |
| 233 | Phosphorylation | LIGQTVSSETIKSIT ECCCCCCHHHHHHHC  | 34.13 | 30576142 | |
| 235 | Phosphorylation | GQTVSSETIKSITGE CCCCCHHHHHHHCCC  | 35.34 | 30576142 | |
| 238 | Phosphorylation | VSSETIKSITGEYIV CCHHHHHHHCCCEEE  | 22.87 | 25072903 | |
| 240 | Phosphorylation | SETIKSITGEYIVMT HHHHHHHCCCEEEEE  | 30.93 | 25072903 | |
| 243 | Phosphorylation | IKSITGEYIVMTVYF HHHHCCCEEEEEEHH  | 10.52 | 25072903 | |
| 247 | Phosphorylation | TGEYIVMTVYFHLRR CCCEEEEEEHHHHHH  | 10.93 | 25072903 | |
| 249 | Phosphorylation | EYIVMTVYFHLRRKM CEEEEEEHHHHHHHH  | 3.98 | 25072903 | |
| 289 | Phosphorylation | KESVPARTVFGITTV CCCCCHHHHCCEEEE  | 23.46 | 30206219 | |
| 294 | Phosphorylation | ARTVFGITTVLTMTT HHHHCCEEEEEEEHH  | 15.95 | 27732954 | |
| 295 | Phosphorylation | RTVFGITTVLTMTTL HHHCCEEEEEEEHHC  | 16.17 | 27732954 | |
| 298 | Phosphorylation | FGITTVLTMTTLSIS CCEEEEEEEHHCCHH  | 14.24 | 27732954 | |
| 300 | Phosphorylation | ITTVLTMTTLSISAR EEEEEEEHHCCHHHH  | 21.25 | 27732954 | |
| 301 | Phosphorylation | TTVLTMTTLSISARH EEEEEEHHCCHHHHC  | 14.00 | 27732954 | |
| 303 | Phosphorylation | VLTMTTLSISARHSL EEEEHHCCHHHHCCC  | 16.65 | 27732954 | |
| 305 | Phosphorylation | TMTTLSISARHSLPK EEHHCCHHHHCCCCC  | 18.84 | 27732954 | |
| 309 | Phosphorylation | LSISARHSLPKVSYA CCHHHHCCCCCCCHH  | 40.59 | 29449344 | |
| 380 | Phosphorylation | PEAPLQNTNANLNMR CCCCCCCCCCCCCHH  | 23.81 | 26091039 | |
| 410 | Phosphorylation | RTEVGNHSSKSSTVV CCEECCCCCCCCCEE  | 43.38 | 24719451 | |
| 411 | Phosphorylation | TEVGNHSSKSSTVVQ CEECCCCCCCCCEEE  | 29.07 | 24719451 | |
| 414 | Phosphorylation | GNHSSKSSTVVQESS CCCCCCCCCEEECCC  | 29.02 | - | |
| 427 | Phosphorylation | SSKGTPRSYLASSPN CCCCCCHHHHCCCCC  | 26.21 | 29116813 | |
| 428 | Phosphorylation | SKGTPRSYLASSPNP CCCCCHHHHCCCCCC  | 13.94 | 29978859 | |
| 431 | Phosphorylation | TPRSYLASSPNPFSR CCHHHHCCCCCCCCC  | 43.67 | 29978859 | |
| 432 | Phosphorylation | PRSYLASSPNPFSRA CHHHHCCCCCCCCCC  | 24.08 | 29116813 | |
| 437 | Phosphorylation | ASSPNPFSRANAAET CCCCCCCCCCCHHHH  | 31.57 | 30576142 | |
| 444 | Phosphorylation | SRANAAETISAARAL CCCCHHHHHHHHHHC  | 18.59 | 30624053 | |
| 446 | Phosphorylation | ANAAETISAARALPS CCHHHHHHHHHHCCC  | 24.24 | 30576142 | |
| 455 | Phosphorylation | ARALPSASPTSIRTG HHHCCCCCCCCCCCC  | 32.80 | 24076635 | |
| 458 | Phosphorylation | LPSASPTSIRTGYMP CCCCCCCCCCCCCCC  | 17.29 | 22985185 | |
| 474 | Phosphorylation | KASVGSASTRHVFGS CCCCCCHHHHHHHHH  | 27.89 | 22817900 | |
| 475 | Phosphorylation | ASVGSASTRHVFGSR CCCCCHHHHHHHHHH  | 25.22 | 21712546 | |
| 481 | Phosphorylation | STRHVFGSRLQRIKT HHHHHHHHHHHHHEE  | 20.53 | 21712546 | |
| 502 | Phosphorylation | ATGKLSATPPPSAPP CCCCCCCCCCCCCCC  | 32.71 | 24260401 | |
| 515 | Phosphorylation | PPPSGSGTSKIDKYA CCCCCCCCCHHCCCH  | 28.66 | 24260401 | 
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources | 
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GBRA4_HUMAN !!  | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GBRA4_HUMAN !!  | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10)  | 
                            							Residue Change | SAP | Related Disease | Reference | 
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GBRA4_HUMAN !!  | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D00058 | Gamma-Aminobutyric acid (JAN); Gammalon (TN) | |||||
| D00225 | Alprazolam (JP16/USP/INN); Xanax (TN) | |||||
| D00267 | Chlordiazepoxide (JP16/USP/INN); Libritabs (TN) | |||||
| D00280 | Clonazepam (JP16/USP/INN); Klonopin (TN) | |||||
| D00293 | Diazepam (JP16/USP/INN); Diastat (TN); Valium (TN) | |||||
| D00311 | Estazolam (JP16/USAN/INN); ProSom (TN) | |||||
| D00329 | Flurazepam (JAN/INN); Insumin (TN) | |||||
| D00331 | Furosemide (JP16/USP/INN); Frusemide; Lasix (TN) | |||||
| D00365 | Lorazepam (JP16/USP/INN); Ativan (TN) | |||||
| D00370 | Temazepam (USP/INN); Restoril (TN) | |||||
| D00376 | Meprobamate (JAN/USP/INN); Equanil (TN); Miltown (TN) | |||||
| D00387 | Triazolam (JAN/USP/INN); Halcion (TN) | |||||
| D00430 | Secobarbital (USP/INN); Seconal (TN) | |||||
| D00457 | Quazepam (JAN/USP/INN); Doral (TN) | |||||
| D00470 | Prazepam (JP16/USAN/INN); Centrax (TN) | |||||
| D00499 | Pentobarbital (USP/INN); Nembutal (TN) | |||||
| D00500 | Pentobarbital sodium (JAN/USP); Nembutal sodium (TN) | |||||
| D00506 | Phenobarbital (JP16/USP/INN); Luminal (TN) | |||||
| D00531 | Nitrazepam (JP16/USAN/INN); Benzalin (TN); Nitrazepam (TN) | |||||
| D00532 | Glutethimide (JAN/INN); Doriden (TN) | |||||
| D00549 | Propofol (JAN/USAN/INN); Diprivan (TN) | |||||
| D00550 | Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN) | |||||
| D00555 | Amobarbital (JP16/INN); Isomytal (TN) | |||||
| D00557 | Methaqualone (JAN/USAN/INN) | |||||
| D00693 | Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) | |||||
| D00694 | Clorazepate dipotassium (JP16/USP); Tranxene (TN) | |||||
| D00695 | Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) | |||||
| D00696 | Midazolam hydrochloride (USAN); Versed (TN) | |||||
| D00697 | Flumazenil (JAN/USP/INN); Romazicon (TN) | |||||
| D00700 | Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) | |||||
| D00701 | Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) | |||||
| D00706 | Zolpidem tartrate (JP16/USAN); Ambien (TN); Intermezzo (TN) | |||||
| D00713 | Thiamylal sodium (JP16); Surital (TN) | |||||
| D00714 | Thiopental sodium (JP16/USP/INN); Pentothal (TN) | |||||
| D01071 | Hexobarbital (JAN/INN) | |||||
| D01230 | Flunitrazepam (JP16/USAN/INN); Rohypnol (TN) | |||||
| D01245 | Bromazepam (JP16/USAN/INN); Lectopam (TN) | |||||
| D01253 | Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) | |||||
| D01254 | Tofisopam (JP16/INN); Emandaxin (TN) | |||||
| D01268 | Cloxazolam (JP16/INN); Sepazon (TN) | |||||
| D01278 | Oxazolam (JP16/INN); Serenal (TN) | |||||
| D01279 | Flutoprazepam (JP16/INN); Restas (TN) | |||||
| D01286 | Flutazolam (JAN/INN); Coreminal (TN) | |||||
| D01292 | Medazepam (JP16/INN); Pamnace (TN) | |||||
| D01293 | Ethyl loflazepate (JAN/INN); Meilax (TN) | |||||
| D01310 | Secobarbital sodium (JAN/USP); Seconal sodium (TN) | |||||
| D01316 | Mexazolam (JAN/INN); Melex (TN) | |||||
| D01328 | Clotiazepam (JP16/INN); Rize (TN) | |||||
| D01354 | Fludiazepam (JP16/INN); Erispan (TN) | |||||
| D01372 | Zopiclone (JAN/INN); Amoban (TN); Zopiclone (TN) | |||||
| D01408 | Flurazepam hydrochloride (JP16); Flurazepam monohydrochloride; Dalmate (TN) | |||||
| D01514 | Etizolam (JP16/INN); Sedekopan (TN) | |||||
| D01564 | Rilmazafone hydrochloride hydrate (JAN); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochlor | |||||
| D01593 | Nimetazepam (JAN/INN); Erimin (TN) | |||||
| D01657 | Lormetazepam (JAN/USAN/INN); Loramet (TN) | |||||
| D01740 | Barbital (JP16/INN); Barbital (TN) | |||||
| D01744 | Brotizolam (JP16/USAN/INN); Lendormin (TN) | |||||
| D01758 | Haloxazolam (JP16/INN); Somelin (TN) | |||||
| D02252 | Amobarbital sodium (JAN/USP); Amytal sodium (TN) | |||||
| D02253 | Pentobarbital calcium (JP16); Ravona (TN) | |||||
| D02283 | Iomazenil (123I) (JAN/INN); Benzodine (TN) | |||||
| D02594 | Abecarnil (INN) | |||||
| D02616 | Pagoclone (USAN/INN); Bextra (TN) | |||||
| D02617 | Ocinaplon (USAN/INN) | |||||
| D02624 | Eszopiclone (JAN/USAN/INN); Estorra (TN); Lunesta (TN) | |||||
| D02833 | Alpidem (USAN/INN) | |||||
| D03155 | Bretazenil (USAN/INN) | |||||
| D03562 | Clorazepate monopotassium (USAN) | |||||
| D03737 | Dextofisopam (USAN/INN) | |||||
| D04257 | Fospropofol disodium (USAN); Aquavan (TN); Lusedra (TN) | |||||
| D04282 | Gaboxadol (USAN/INN) | |||||
| D04300 | Ganaxolone (USAN/INN) | |||||
| D04721 | Levotofisopam (USAN/INN) | |||||
| D04882 | Medazepam hydrochloride (USAN); Nobrium (TN) | |||||
| D05028 | Midazolam maleate (USAN) | |||||
| D06106 | Thiamylal | |||||
| D07326 | Loprazolam (INN); Dormonoct (TN) | |||||
| D07409 | Pentetrazol (INN); Pentylenetetrazol; Coryvet [veterinary] (TN) | |||||
| D07784 | Delorazepam (INN); Dadumir (TN) | |||||
| D07999 | Sodium furosemide; Frosemide sodium; Lasix (TN) | |||||
| D08001 | Furosemide diolamine; Furosemide diethanolamine salt; Nuriban (TN) | |||||
| D08145 | Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) | |||||
| D08283 | Nordazepam (INN); Calmday (TN) | |||||
| D08356 | Phenobarbital diethylamine; Gratusminal (TN) | |||||
| D08481 | Rilmazafone (INN) | |||||
| D08507 | Sarmazenil (INN); Sarmazol [veterinary] (TN) | |||||
| D08690 | Zolpidem (INN); Sanval (TN) | |||||
| D08840 | Adipiplon (USAN) | |||||
| D10194 | Remimazolam besilate (JAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed | 
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-142, ANDMASS SPECTROMETRY.  | |